Collegium Pharmaceutical, Inc. (COLL) Q4 2015 Earnings Results

Collegium Pharmaceutical Misses on EPS, Stock Down 3.59%

Collegium Pharmaceutical reported a loss per share of $0.46, which was below expectations. The stock reacted negatively, declining by 3.59%. The lack of revenue data and management commentary leaves uncertainty about the company's performance and future direction.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.46	N/A	-0.66%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record for the earnings call, and the analysis is based solely on numerical results.

Collegium Pharmaceutical Misses on EPS, Stock Down 3.59%

Key numbers

Management commentary

Collegium Pharmaceutical, Inc.

More earnings this week

Collegium Pharmaceutical Misses on EPS, Stock Down 3.59%

Key numbers

Management commentary